These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 29412697)

  • 1. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
    Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
    Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B
    PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
    Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR.
    Yu Z; Li N; Jiang K; Zhang N; Yao LL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-19b-3p relieves intervertebral disc degeneration through modulating PTEN/PI3K/Akt/mTOR signaling pathway.
    Zhao Y; Li A
    Aging (Albany NY); 2021 Sep; 13(18):22459-22473. PubMed ID: 34554926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-17 targets PTEN and facilitates glial scar formation after spinal cord injuries via the PI3K/Akt/mTOR pathway.
    Luan Y; Chen M; Zhou L
    Brain Res Bull; 2017 Jan; 128():68-75. PubMed ID: 27693649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of miR-21 on hypertensive rats through PTEN/PI3K/Akt/mTOR signaling pathway.
    Shi YJ; Xu W; Han YF; Li JX; Niu LL; Chen YD
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4924-4931. PubMed ID: 31210327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
    Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN.
    Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J
    Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular Fluid-Derived Exosomal MicroRNA-18b-5p Regulates PTEN-Mediated PI3K/Akt/mTOR Signaling Pathway to Inhibit Polycystic Ovary Syndrome Development.
    Zhou Z; Tu Z; Zhang J; Tan C; Shen X; Wan B; Li Y; Wang A; Zhao L; Hu J; Ma N; Zhou J; Chen L; Song Y; Lu W
    Mol Neurobiol; 2022 Apr; 59(4):2520-2531. PubMed ID: 35092573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
    Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
    Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
    Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.